IBEC researchers have come a step closer to understanding how bacteria can cause chronic infections by identifying the key enzymes that allow them to create the right conditions for infection. Their f...
Read moreIproteos, con sede en el Parc Científic de Barcelona (PCB), ha lanzado una campaña de equity crowdfunding (microinversión por acciones) de 250,000 euros a través de la plataforma Capital Cell. Los...
Read moreCollaboration boosts development of a fully differentiated inhibitor of the PI3K/Akt/mTOR pathway. ABTL0812 is currently in Phase 2 clinical trials to treat lung and endometrial cancers.
Read moreLa empresa GlaxoSmithKline ha presentado a los investigadores el programa Discovery Partnerships with Academia (DPAC), una iniciativa de innovación abierta que tiene el objetivo de reunir investigado...
Read moreLa unidad, coordinada por el Dr. Javier García-Corbacho, es una de las pocas en Europa que obtiene este reconocimiento que permitirá proporcionar fármacos de acceso restringido a los pacientes con ...
Read moreLa publicación de un genoma reducirá costes de producción e impacto medioambiental en la producción de esteroideos de uso médico.
Read moreLa Food and Drug Administration (FDA), la agencia del gobierno de los Estados Unidos responsable de la regulación de los medicamentos, ha designado Fancalen, un vector lentiviral que contiene el gen ...
Read morexenOPAT, which offers anti-cancer drug development services, has participated in this first edition of INNOVA Barcelona through IDIBELL and its area of Innovation and Business Development
Read moreResearchers have found heparin-like molecules with reduced blood-thinning activity that can be used for therapeutic approaches against malaria – in sea cucumbers, red algae and marine sponges.
Read moreThe company will allocate the capital to advance the preclinical development of its prioritized product – a first in class drug for multiple mieloma treatment, to set up new discovery programs, and ...
Read morePrice of hepatitis C drug in Spain is 277 times the cost of production, according to a new ISGlobal publication.
Read moreLos ensayos clínicos son una parte esencial del proceso investigador. Un fármaco puede tardar más de seis años en superar esta fase. Consciente de ello, Farmaindustria constituyó en 2005 la Plata...
Read more